| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
Nasdaq: AZMA |
| Security Type |
Common Stock |
| Lead Underwriter |
Piper Jaffray Cos Bear Stearns & Co Inc |
| Days In Registration |
127 |
| Date Filed |
24-Jul-2006 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
The company is focused in manufacturing therapeutic treatment for asthma; They have developed and designed a procedure called Bronchial Thermoplasty in which controlled thermal energy is delivered through the airwaves of adult patients, reducing the mass of airway smooth muscle; This procedure decreases the ability of airways to constrict; thus providing a therapeutic benefit to the asthma patient; The company is the developer of a device called the Alair System, specifically designed to apply Bronchial Thermoplasty; |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
16.01M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
5.0M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
750.0K |
| File Amount |
- |
| File Price Range |
$13.00 - $11.00 |
| File Mid Price |
$12.00 |
|
